Table 2

Age and sex distribution of subjects screened and age specific prevalence

Age group (y)		Screened				TAN patients			Prevalence (%)
Age group (y)		Male	Female			Male	Female		Male	Female
10–19	566	508		3	3		0.5	0.6
20–29	222	356		1	4		0.5	1.1
30–39	186	272		1	10		0.5	3.7
40–49	161	199		5	19		3.1	10.0
50–59	134	193		5	36		3.7	18.7
60–69	153	168		24	41		15.7	24.4
70–79	81	108		14	24		17.3	22.2
>80	44	77		8	8		18.0	10.4
Total	1547	1881		61	145		3.9	7.7